EGFR and hepatocellular carcinoma: It was shown that G144AXXXG148A mutation strongly diminished the interaction between NTCP and EGFR, finally leading to decreased preS1-peptide binding and HBV/HDV infection rates in NTCP-transfected hepatoma cells (Iwamoto et al., 2019).